Literature DB >> 28171706

Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet.

Jennifer T Saville1, Hong Ngoc Thai1, Rebecca J Lehmann1, Ainslie L K Derrick-Roberts1,2, Maria Fuller1,2.   

Abstract

Gangliosides are the most complex oligosaccharide-containing glycosphingolipids defined by the presence of sialic acid and although present in all tissues, predominate in the brain. Considering their importance in neural development, it is unsurprising that ganglioside metabolism is altered in neurodegenerative diseases. The severe form of mucopolysaccharidosis type I, Hurler syndrome (HS), is characterised by progressive loss of neuronal function through largely undefined mechanisms. Here, we sought to interrogate brain gangliosides in a murine model of HS and further, assessed whether dietary modulation of lipid metabolism effected correction of the metabolic abnormalities. The simple gangliosides, GM2 , GM3 , GD2 and GD3 were elevated in the five subregions examined - brain stem, cerebellum, cortex, hippocampus, subcortex - in HS mice as early as 2 months of age compared with their wild type counterparts. Their elevation persisted at 6 months of age, imparting protracted neurological development as these simple gangliosides have usually subsided by this stage of brain development. Their immediate synthetic precursor, lactosylceramide, was also elevated, suggesting that their increase arises at this metabolic intermediary, as dihydroceramide, ceramide and monohexosylceramide were unaffected. Dietary linoleic acid supplementation significantly reduced GM2 and GM3 , and furthermore, improved exploratory behaviour as assessed by the open field test, highlighting the possibility of further exploring dietary intervention as a therapeutic consideration.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  gangliosides; inborn error of metabolism; linoleic acid; mouse model; neurological disease; tandem mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 28171706     DOI: 10.1111/jnc.13976

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Globoid cell leukodystrophy (Krabbe disease) in a Merino sheep.

Authors:  Effie Lee; Maria Fuller; Mandi Carr; Jim Manavis; John Finnie
Journal:  J Vet Diagn Invest       Date:  2018-10-17       Impact factor: 1.279

2.  Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

Authors:  Steven Q Le; Igor Nestrasil; Shih-Hsin Kan; Martin Egeland; Jonathan D Cooper; David Elashoff; Rong Guo; Jakub Tolar; Jennifer K Yee; Patricia I Dickson
Journal:  Lipids       Date:  2020-06-14       Impact factor: 1.880

3.  Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.

Authors:  Akhil Bhalla; Ritesh Ravi; Meng Fang; Annie Arguello; Sonnet S Davis; Chi-Lu Chiu; Jessica R Blumenfeld; Hoang N Nguyen; Timothy K Earr; Junhua Wang; Giuseppe Astarita; Yuda Zhu; Damian Fiore; Kimberly Scearce-Levie; Dolores Diaz; Heather Cahan; Matthew D Troyer; Jeffrey M Harris; Maria L Escolar
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

4.  The long and the short of Huntington's disease: how the sphingolipid profile is shifted in the caudate of advanced clinical cases.

Authors:  Gabrielle R Phillips; Jennifer T Saville; Sarah E Hancock; Simon H J Brown; Andrew M Jenner; Catriona McLean; Maria Fuller; Kelly A Newell; Todd W Mitchell
Journal:  Brain Commun       Date:  2021-12-23

5.  Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disorders.

Authors:  Murtaza S Nagree; Tania C Felizardo; Mary L Faber; Jitka Rybova; C Anthony Rupar; S Ronan Foley; Maria Fuller; Daniel H Fowler; Jeffrey A Medin
Journal:  EMBO Mol Med       Date:  2022-03-17       Impact factor: 12.137

6.  Elevation of gangliosides in four brain regions from Parkinson's disease patients with a GBA mutation.

Authors:  Shani Blumenreich; Tamar Nehushtan; Or B Barav; Jennifer T Saville; Tamir Dingjan; John Hardy; Maria Fuller; Anthony H Futerman
Journal:  NPJ Parkinsons Dis       Date:  2022-08-06

Review 7.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

Review 8.  Control of Innate Immunity by Sialic Acids in the Nervous Tissue.

Authors:  Huan Liao; Christine Klaus; Harald Neumann
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

9.  Sex-Specific ADHD-like Behaviour, Altered Metabolic Functions, and Altered EEG Activity in Sialyltransferase ST3GAL5-Deficient Mice.

Authors:  Tatyana Strekalova; Ekaterina Veniaminova; Evgeniy Svirin; Ekaterina Kopeikina; Tatyana Veremeyko; Amanda W Y Yung; Andrey Proshin; Shawn Zheng Kai Tan; Sharafuddin Khairuddin; Lee Wei Lim; Klaus-Peter Lesch; Susanne Walitza; Daniel C Anthony; Eugene D Ponomarev
Journal:  Biomolecules       Date:  2021-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.